Search Results
Site Search
This three-day virtual conference offered for just a few hours each day will offer the opportunity to learn techniques for managing burnout and ways to create a positive patient experience. Attendees will have the option to select from a...
This three-day virtual conference offered for just a few hours each day will offer the opportunity to learn techniques for managing burnout and ways to create a positive patient experience. Attendees will have the option to select from a...
This three-day virtual conference offered for just a few hours each day will offer the opportunity to learn techniques for managing burnout and ways to create a positive patient experience. Attendees will have the option to select from a...
This three-day virtual conference offered for just a few hours each day will offer the opportunity to learn techniques for managing burnout and ways to create a positive patient experience. Attendees will have the option to select from a...
This three-day virtual conference offered for just a few hours each day will offer the opportunity to learn techniques for managing burnout and ways to create a positive patient experience. Attendees will have the option to select from a...
Our serum test is the first preeclampsia-specific test that can be used to stratify patients into low- or high-risk categories, indicating whether a patient is at risk for developing preeclampsia with severe features.
The Power of Discovery: Mayo Clinic Laboratories Autoimmune Neurology Service - Insights
Autoimmune neurological disorders can often be treated, sometimes with full restoration of function. However, because the symptoms mimic other conditions, autoimmune neurological disorders are frequently misdiagnosed, resulting in an...
Hereditary Alzheimer's disease and dementia - Insights
Learn about our genetic testing for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), frontotemporal dementia, and CADASIL.
July 2023 - Breast Pathology Case 2 - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Breast Pathology.
Mitochondrial Disease [Test in Focus] - Insights
Linda Hasadsri, M.D., Ph.D., explains how Mayo Clinic Laboratories’ inclusive approach to mitochondrial disease testing expedites diagnosis. Using innovative methodologies like custom reagents and droplet digital PCR enables precision...
Liver Disease Testing - Mayo Clinic Laboratories
Mayo Clinic Laboratories offers the only comprehensive testing menu for liver disease developed by clinical experts that enables health care providers to determine the underlying cause and rule out other causes for the disease.
August 2023 - Clinical Chemistry - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Chemistry.
Dementia with Lewy bodies, Parkinson's, and multiple system atrophy - Insights
Learn more about how Mayo Clinic Laboratories' cerebrospinal fluid biomarker test for synucleinopathies, such as Parkinson’s disease and dementia with Lewy bodies, can accurately identify α-syn pathology even before definitive symptoms...
Precision therapeutics - Insights
At Mayo Clinic Laboratories, utilization of precision therapeutics, or pharmacogenomic testing used in conjunction with therapeutic drug monitoring, provides personalized insights to guide and monitor prescription medication use.
Unique pediatric evaluation targets relevant autoimmune/CNS antibodies - Insights
Andrew McKeon, M.B., B.Ch., M.D., explains how Mayo Clinic Laboratories' pediatric autoimmune/CNS testing can better guide the treatment of autoimmune neurological diseases in children. The tailored evaluation covers only biomarkers...
Answers From the Lab - Insights
A Mayo Clinic podcast sharing knowledge and advances in testing, laboratory science, and the people who make it all happen behind the scenes. Note: Podcasts will not play back on Internet Explorer. Please use an alternative web browser, or...
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) - Insights
Divyanshu (Div) Dubey, M.B.B.S., describes Mayo Clinic Laboratories' new diagnostic test for CIDP, or chronic inflammatory demyelinating polyneuropathy. The new test detects two antibodies — NF155 and CNTN1 — to enhance diagnosis and guide...
Antibody Prevalence in Epilepsy and Encephalopathy (APE2) Score - Insights
In this month’s “Hot Topic,” Divyanshu Dubey, M.B.B.S., discusses how patients with encephalopathy and/or epilepsy of unknown etiology may have an autoimmune or paraneoplastic cause.
Phlebotomy Top Gun: Safe Handling of Laboratory Specimens During the COVID-19 Pandemic - Insights
In this month’s “Hot Topic,” Brad Karon, M.D., Ph.D., addresses the safe handling of laboratory specimens submitted during the COVID-19 pandemic through his yearly Phlebotomy Top Gun presentation based on the previous year’s Phlebotomy...
Platelet Transmission Electron Microscopy and Flow Cytometry - Insights
In this "Hot Topic," Dong Chen, M.D., Ph.D., describes how flow cytometry, electron micrographic study, and molecular testing are used to diagnose platelet function disorders.
Detection of (1→3)-𝝱-D-glucan as a Marker of Invasive Fungal Disease - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the detection of (1→3)-β-D-glucan (BDG) in serum as a biomarker for the presence of invasive fungal infections.
QuantiFERON-TB Gold Plus - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D. will discuss a new interferon-gamma release assay that can assist in the detection of individuals that are infected with tuberculosis.
New tests launched in January - Insights
In January 2023, Mayo Clinic Laboratories announced fifty-nine new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Antibody Prevalence in Epilepsy and Encephalopathy (APE2) Score - Insights
In this month’s “Hot Topic,” Divyanshu Dubey, M.B.B.S., discusses how patients with encephalopathy and/or epilepsy of unknown etiology may have an autoimmune or paraneoplastic cause.
Lyme Neuroborreliosis - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss diagnostic testing options for patients with suspected neuroinvasive Lyme disease or Lyme neuroborreliosis.
A Test in Focus Archives - Page 3 of 11 - Insights
Skip to Content MayoACCESS MayoLINK Register My Dashboard...
A Test in Focus Archives - Insights
Skip to Content MayoACCESS MayoLINK Register My Dashboard...
Find out how our hereditary cancer panels use next-generation sequencing to evaluate dozens of genes associated with cancer risk.
Morris Hospital & Healthcare Centers: Expanding diagnostic care in a rural community - Insights
By collaborating with Mayo Clinic Laboratories, Morris Hospital & Healthcare Center has been able to expand complex and specialized lab testing in the communities they serve.
Renal Pathology at Mayo Clinic Laboratories
Mayo Clinic Laboratories’ is integrated with the Renal Biopsy Laboratory in the Department of Laboratory Medicine and Pathology at Mayo Clinic. Board-certified pathologist have a special interest in non-neoplastic disease of the kidney and...
Addiction rehabilitation monitoring - Insights
Encompassing comprehensive profiles, confirmatory testing, and interpretive results reporting, addiction rehabilitation monitoring at Mayo Clinic Laboratories supports patients affected by substance use disorder in their rehabilitation and...
Malabsorption panel: Filling a gap in pediatric care - Insights
Mayo Clinic Laboratories is committed to innovation that provides the right test at the right time for the right patients. That effort always starts with identifying gaps in patient care. Filling those gaps sometimes involves not developing...
Bile acid malabsorption - Insights
Chronic diarrhea and abdominal pain can be caused by many conditions, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), Celiac disease, infectious GI pathogens, and malignancy. When other causes of chronic diarrhea...
Lymphomas Testing - Mayo Clinic Laboratories
To assist clinicians with lymphoma diagnosis, Mayo Clinic has a highly experienced, 9-member hematopathology section focusing on lymphoma diagnosis, which diagnoses more than 3,000 lymphoma cases per year.
Learn how Mayo Clinic Laboratories testing for adrenal diseases can help physicians detect and classify adrenal disorders.
Medication-targeted testing - Insights
Learn more about how medication targeted testing at Mayo Clinic Laboratories can assist in treatment optimization for medication with established pharmacogenomic associations.
Bobbi Pritt, M.D., Advises How to Avoid Bug-Borne Diseases This Summer - Insights
Bobbi Pritt, M.D., Director of the Clinical Parasitology Lab and Co-Director of Vector-Borne Diseases Lab Services in Mayo Clinic’s Department of Lab Medicine and Pathology, recently spoke with the Post-Bulletin about Lyme disease and West...
Using metal detectors to ward off wayward specimens - Insights
To safeguard patient samples, staff in Mayo Clinic’s Histology Laboratory devised an inventive way to ensure that none of the paraffin-embedded blocks processed in the lab ever ends up in the trash.
A Test in Focus Archives - Page 2 of 11 - Insights
Skip to Content MayoACCESS MayoLINK Register My Dashboard...
Communiqué Archives - Page 3 of 4 - Insights
Skip to Content MayoACCESS MayoLINK Register My Dashboard...
Yuma Regional Medical Center: Strategic expansion to serve a growing community - Insights
Faced with a population increase and the need to expand both laboratory testing capacity and capabilities, Yuma Regional Medical Center leaned into its relationship with Mayo Clinic Laboratories to gain insights to strengthen community...
Improving outcomes through comprehensive controlled substance monitoring - Insights
Controlled substance testing options vary in the details they provide about patient drug use, painting an incomplete picture of usage patterns that can hinder accurate prescription monitoring and treatment outcomes. However, a new...
New tests launched in October - Insights
In October 2022, Mayo Clinic Laboratories announced thirty new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New tests launched in October - Insights
In October 2021, Mayo Clinic Laboratories announced eleven new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Outreach & Business Solutions - Insights
Mayo Clinic Laboratories’ Outreach Program equips laboratory leaders with Mayo Clinic expertise and customized strategies to help grow laboratory revenues by increasing efficiencies and minimizing waste.
GFAP: Novel Test for a Newly Identified Meningoencephalomyelitis - Insights
Mayo Clinic Laboratories is the only laboratory in the world to offer testing for a novel form of autoimmune meningoencephalomyelitis. Known as autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy, the condition was identified...
Saving and improving lives: The illuminating journey of a laboratory testing specimen - Insights
Check out the first episode of “Life of a Specimen,” a video series that examines the critical journey taken by patient samples through Mayo Clinic Laboratories testing. In this video, we learn about the profound impact of our testing on...
Nonradioactive assay helps diagnose heparin reaction - Insights
Rajiv Pruthi, M.B.B.S., explains how Mayo Clinic Laboratories’ serotonin release assay achieves high sensitivity and specificity while avoiding the use of radioactive materials. Serotonin release testing is an important tool in the...
Learn more about how Mayo Clinic Laboratories’ test offerings and services can help hospital laboratories enhance patient care and laboratory performance.
Learn more about matrix-assisted laser desorption/ionization-time of flight mass spectrometry and the identification of plasma cell disorders.